Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Prevalence of Onchocerciasis in Africa and Yemen, 2000–2018: A Geospatial Analysis Publisher Pubmed



Schmidt CA1 ; Cromwell EA1, 2 ; Hill E1 ; Donkers KM1 ; Schipp MF1 ; Johnson KB1 ; Pigott DM1, 2 ; Abbas J3 ; Adekanmbi V4 ; Adetokunboh OO5, 6 ; Ahmed MB7, 8 ; Alanezi FM9 ; Alanzi TM10 ; Alipour V11, 12 Show All Authors
Authors
  1. Schmidt CA1
  2. Cromwell EA1, 2
  3. Hill E1
  4. Donkers KM1
  5. Schipp MF1
  6. Johnson KB1
  7. Pigott DM1, 2
  8. Abbas J3
  9. Adekanmbi V4
  10. Adetokunboh OO5, 6
  11. Ahmed MB7, 8
  12. Alanezi FM9
  13. Alanzi TM10
  14. Alipour V11, 12
  15. Andrei CL13
  16. Andrei T14
  17. Anvari D15, 16
  18. Appiah SCY17, 18
  19. Aqeel M19
  20. Arabloo J11
  21. Jafarabadi MA20, 21
  22. Ausloos M14, 22
  23. Baig AA23
  24. Banach M24, 25
  25. Barnighausen TW26, 27
  26. Bhattacharyya K28, 29
  27. Bhutta ZA30, 31
  28. Bijani A32
  29. Brady OJ33
  30. Bragazzi NL34
  31. Butt ZA35, 36
  32. Carvalho F37
  33. Chattu VK38, 39
  34. Dahlawi SMA40
  35. Damiani G41, 42
  36. Demeke FM43
  37. Deribe K44, 45
  38. Dharmaratne SD1, 2, 46
  39. Diaz D47, 48
  40. Didarloo A49
  41. Earl L1
  42. Zaki MES50
  43. El Tantawi M51
  44. Fattahi N52
  45. Fernandes E53
  46. Foigt NA54
  47. Foroutan M55, 56
  48. Franklin RC57
  49. Guo Y58, 59
  50. Hajmirzaian A60, 61
  51. Hamidi S62
  52. Hassankhani H63
  53. Herteliu C14, 65
  54. Higazi TB66
  55. Hosseini M67, 68
  56. Hosseinzadeh M69, 70
  57. Househ M71
  58. Ilesanmi OS72, 73
  59. Ilic IM74
  60. Ilic MD75
  61. Irvani SSN64
  62. Jha RP76, 77
  63. Ji JS78
  64. Jonas JB79, 80
  65. Jozwiak JJ81
  66. Kalankesh LR82
  67. Kamyari N83
  68. Matin BK52
  69. Karimi SE84
  70. Kayode GA85, 86
  71. Karyani AK52
  72. Khan EA87
  73. Khan MN88
  74. Khatab K89, 90
  75. Khater MM91
  76. Kianipour N92
  77. Kim YJ93
  78. Kosen S94
  79. Kusuma D95, 96
  80. La Vecchia C97
  81. Lansingh VC98, 99
  82. Lee PH100
  83. Li S101
  84. Maleki S102
  85. Mansournia MA67
  86. Martinsmelo FR103
  87. Mcalinden C104
  88. Mendoza W105
  89. Mestrovic T106, 107
  90. Moghadaszadeh M108, 109
  91. Mohammadianhafshejani A110
  92. Mohammadi SM111
  93. Mohammed S112, 113
  94. Moradzadeh R114
  95. Moraga P115
  96. Naderi M102
  97. Nagarajan AJ116, 117
  98. Negoi I118, 119
  99. Nguyen CT120
  100. Nguyen HLT120
  101. Oancea B121
  102. Olagunju AT122, 123
  103. Bali AO124
  104. Onwujekwe OE125
  105. Pana A14, 126
  106. Rahimimovaghar V127
  107. Ramezanzadeh K60
  108. Rawaf DL128, 129
  109. Rawaf S130, 131
  110. Rawassizadeh R132
  111. Rezapour A11
  112. Ribeiro AI133
  113. Samy AM134
  114. Shaikh MA135
  115. Sharafi K52
  116. Sheikh A136, 137
  117. Singh JA138, 139
  118. Skiadaresi E140
  119. Soltani S52
  120. Stolk WA141
  121. Sufiyan MB142
  122. Thomson AJ143
  123. Tran BX144
  124. Tran KB145, 146
  125. Unnikrishnan B147
  126. Violante FS148, 149
  127. Vu GT150
  128. Yamada T151
  129. Yaya S152, 153
  130. Yip P154, 155
  131. Yonemoto N156, 157
  132. Yu C158
  133. Yu Y159
  134. Zamanian M114
  135. Zhang Y160, 161
  136. Zhang ZJ162
  137. Ziapour A163
  138. Hay SI1, 2

Source: BMC Medicine Published:2022


Abstract

Background: Onchocerciasis is a disease caused by infection with Onchocerca volvulus, which is transmitted to humans via the bite of several species of black fly, and is responsible for permanent blindness or vision loss, as well as severe skin disease. Predominantly endemic in parts of Africa and Yemen, preventive chemotherapy with mass drug administration of ivermectin is the primary intervention recommended for the elimination of its transmission. Methods: A dataset of 18,116 geo-referenced prevalence survey datapoints was used to model annual 2000–2018 infection prevalence in Africa and Yemen. Using Bayesian model-based geostatistics, we generated spatially continuous estimates of all-age 2000–2018 onchocerciasis infection prevalence at the 5 × 5-km resolution as well as aggregations to the national level, along with corresponding estimates of the uncertainty in these predictions. Results: As of 2018, the prevalence of onchocerciasis infection continues to be concentrated across central and western Africa, with the highest mean estimates at the national level in Ghana (12.2%, 95% uncertainty interval [UI] 5.0–22.7). Mean estimates exceed 5% infection prevalence at the national level for Cameroon, Central African Republic, Democratic Republic of the Congo (DRC), Guinea-Bissau, Sierra Leone, and South Sudan. Conclusions: Our analysis suggests that onchocerciasis infection has declined over the last two decades throughout western and central Africa. Focal areas of Angola, Cameroon, the Democratic Republic of the Congo, Ethiopia, Ghana, Guinea, Mali, Nigeria, South Sudan, and Uganda continue to have mean microfiladermia prevalence estimates exceeding 25%. At and above this level, the continuation or initiation of mass drug administration with ivermectin is supported. If national programs aim to eliminate onchocerciasis infection, additional surveillance or supervision of areas of predicted high prevalence would be warranted to ensure sufficiently high coverage of program interventions. © 2022, The Author(s).
Other Related Docs